Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (30)
NITAG documentation (1591)
Reports (55)
SAGE documentation (218)
Scientific publications (112)
Systematic reviews (SYSVAC) (2750)
Regions
Africa (267)
Americas (762)
Eastern Mediterranean (48)
Europe (704)
South-East Asia (78)
Western Pacific (196)
Diseases
Chikungunya (9)
Cholera (33)
COVID-19 (1481)
Cytomegalovirus (1)
Dengue (39)
Diphtheria (79)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (66)
Hepatitis A (63)
Hepatitis B (153)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (66)
HIV / AIDS (10)
Human papillomavirus (HPV) (472)
Influenza (573)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (27)
Measles (128)
Meningococcal disease (145)
Mpox (55)
Mumps (46)
Pertussis (104)
Pneumococcal disease (266)
Poliomyelitis (84)
Q fever (1)
Rabies (28)
Rotavirus (115)
RSV (Respiratory syncytial virus) (47)
Rubella (64)
Salmonella (2)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (59)
Tick-borne encephalitis (12)
Tuberculosis (73)
Typhoid (23)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
4756 results found
2021
Interim Recommendations on the Use of COVID-19 Vaccines in Nigeria
2021
∙
Sara Oliver, ACIP
Janssen COVID-19 Vaccine - ACIP conclusion
2021
∙
JCVI
JCVI Advice on influenza vaccines for 2022/23
2021
∙
JCVI
JCVI advice on the UK vaccine response to the Omicron variant
2021
∙
JCVI
JCVI advice on Third primary COVID-19 vaccine dose for people who are immunosuppressed - 1 September, 2021
2021
∙
JCVI
JCVI advice to mitigate impact of B1.617.2 variant - 14 May 2021
2021
∙
JCVI
JCVI advises on the use of the coronavirus (COVID-19) Oxford/AstraZeneca vaccine for people aged under 40 - 7 May 2021
2021
∙
JCVI
JCVI final statement on phase 2 of the COVID-19 vaccination programme: 13 April, 2021
2021
∙
JCVI
JCVI interim advice: potential COVID-19 booster vaccine programme winter 2021 to 2022 - 30 June 2021
2021
∙
JCVI, Public Health England
JCVI interim statement on phase 2 of the COVID-19 vaccination programme
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register